SAM
OPRX icon

Silvercrest Asset Management’s OptimizeRx OPRX Stock Holding History

Silvercrest Asset Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-120,136
Closed -$7.44M – 867
2021
Q2 		$7.44M Sell
120,136
-337
-0.3% -$17.1K 0.05% 323
2021
Q1 		$5.87M Sell
120,473
-151,819
-56% -$7.33M 0.04% 354
2020
Q4 		$8.48M Sell
272,292
-46,489
-15% -$1.14M 0.06% 267
2020
Q3 		$6.65M Sell
318,781
-6,151
-2% -$106K 0.06% 283
2020
Q2 		$4.23M Buy
+324,932
New +$3.53M 0.04% 356

Other funds holding OPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Silvercrest Asset Management's OPRX Position: Q3 2021 in Review

Silvercrest Asset Management sold out of OptimizeRx (OPRX) in Q3 2021, closing a stake of 120,136 shares — an estimated $7.44M sold.

Silvercrest Asset Management first reported a position in OPRX in Q2 2020 and held it in 5 quarters. The position peaked at $8.48M in Q4 2020. 163 funds tracked by Wall St. Rank hold OPRX as of Q3 2021.

  • Silvercrest Asset Management reported no remaining OptimizeRx position as of Q3 2021 after selling out during the quarter.
  • Silvercrest Asset Management sold 120,136 OptimizeRx shares in Q3 2021, an estimated $7.44M.
  • Silvercrest Asset Management first reported a position in OptimizeRx in Q2 2020 and held it in 5 quarters.
  • Silvercrest Asset Management's OptimizeRx position peaked at $8.48M in Q4 2020.
  • 163 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2021.

Based on Silvercrest Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.